Business idea

NemerPharma will provide the industry with a economical and ecological sustainable production of TTX

News

March 2011: Nominated company at MareLife
Sep 2010: PCT application regarding NemerPharmas TTX protocol is filed.
May 2010: NemerPharma welcomes Neven Zoric, Håkan Stenson and Tore Sveälv as new board members
Mar 2010: Collaboration with Prof Henrik Pavia regarding a natural but controlled Saxitoxin production
Dec 2009: Second investment round by GU Holding in NemerPharma
Nov 2009: NemerPharama receives 380 000 Skr grant from Sahlgrenska Science park and BioGöteborg
Nov 2009: NemerPharma makes valuable contacts at Biotechnologu Partnering Conference, BioEurope in Vienna
Sep 2009: Scientific collaboration agreement signed with Ramidus AB
Sep 2009: Provisional patent concerning NemerPharmas TTX protocol is filed
Dec 2008: GU Holding invests in Nemerpharma
Dec 2008: Establishment of NemerPharma
Sep 2008: PhD Malin Strand and Prof  Per Sundberg receives a 200 000 Skr grant from Innovationsbron for their idea “Production of a marine bioactive compound for pharmaceutical applications”